Progress Towards Synthesis of Acyclic Hydrazide-based Nucleoside Mimics as Potential Antiviral Drug Candidates

Presenter Information

Bi Han, Seattle University

Faculty Information

Joseph Langenhan | Course: CHEM 4990 | Project-in-progress

Presentation Type

Individual

Presentation Format

Poster

Start Date

10-5-2024 12:00 PM

End Date

10-5-2024 1:00 PM

Abstract or artist statement

Nucleoside analogs are a valuable source of potential antiviral drugs. For example, the nucleoside AZT is a well-known drug used to treat HIV infections and molnupiravir is approved to treat SARS-CoV-2 infections. Simple acyclic nucleoside analogs like ganciclovir have also been employed in the clinic as antivirals. We report here the synthesis of a novel class of acyclic hydrazide-based nucleoside mimics which will be evaluated for possible antiviral activity.

Keywords: Synthetic organic chemistry for developing antiviral molecules

This document is currently not available here.

Share

COinS
 
May 10th, 12:00 PM May 10th, 1:00 PM

Progress Towards Synthesis of Acyclic Hydrazide-based Nucleoside Mimics as Potential Antiviral Drug Candidates

Nucleoside analogs are a valuable source of potential antiviral drugs. For example, the nucleoside AZT is a well-known drug used to treat HIV infections and molnupiravir is approved to treat SARS-CoV-2 infections. Simple acyclic nucleoside analogs like ganciclovir have also been employed in the clinic as antivirals. We report here the synthesis of a novel class of acyclic hydrazide-based nucleoside mimics which will be evaluated for possible antiviral activity.

Keywords: Synthetic organic chemistry for developing antiviral molecules